This content is machine translated CLL11 study Combination of chlorambucil and CD20 antibody the new standard as early as 2014? In an interview with InFo ONCOLOGY & HEMATOLOGY, Michael Gregor, MD, of Lucerne Cantonal Hospital, talks about the CLL11 trial. It addresses the study population, the most relevant results, and…
View Post 2 min This content is machine translated Palliative care and pain therapy The need for qualified care will grow Palliative care (PC) has taken off since the late 1960s, especially in Anglo-Saxon countries, after Dame Cicley Saunders was able to open the first hospice in London. In Switzerland, too,…
View Post 3 min This content is machine translated Frontal meningioma Good prognosis after surgical extirpation Case report: A 31-year-old, previously internally healthy woman was admitted for psychiatric treatment due to increasing disorientation and neglect. She described a lack of drive and limitation of memory that…
View Post 4 min This content is machine translated Lymphomas What the family doctor needs to know At the SGIM Great Update in Interlaken, the most common problems and challenges that a family physician encounters when dealing with patients suffering from lymphoma were discussed. The only difficulty…
View Post 4 min This content is machine translated Gastric Cancer Targeted therapies in HER2-positive tumors. To what extent does the biological understanding of the disease help define the therapy? This question was discussed at the ASCO-GI in San Francisco with regard to potential treatment options…
View Post 4 min This content is machine translated Lung, kidney cancer and chronic myeloid leukemia What does modern clinical practice look like? At the DGHO Congress in Vienna, various aspects in clinical practice in non-small cell lung cancer (NSCLC), renal cell cancer (RCC) and chronic myeloid leukemia were addressed. In particular, the…
View Post 2 min This content is machine translated Stage 2 analysis of the CLL11 study Is the chlorambucil combination with GA101 superior to that with rituximab? At the ASH Congress in New Orleans, one of the topics was the CLL11 Phase 3 trial. After showing in the last issue of InFo ONCOLOGY & HEMATOLOGY that the…
View Post 3 min This content is machine translated Non-Hodgkin's Lymphoma Pomalidomide in high-risk patients. Because data on the efficacy of pomalidomide in high-risk relapsed/refractory multiple myeloma populations are sparse, a phase II study set out to evaluate the agent in patients with GEP70 or…
View Post 3 min This content is machine translated Follicular lymphoma Rituximab in maintenance monotherapy. A study presented at ASH 2013 in New Orleans examined the role of rituximab in maintenance therapy in patients with follicular lymphoma. The study showed that the drug, when applied…
View Post 3 min This content is machine translated Newly diagnosed multiple myeloma Does a proteasome inhibitor offer new therapeutic options? One study discussed at the ASH meeting involved a regimen consisting of oral MLN9708 administered twice weekly plus lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma. It concludes…
